China Pharma Holdings Stock Story
| CPHI Stock | USD 0.32 0.02 6.67% |
Under 55% of China Pharma's traders are presently thinking to get in. The analysis of overall sentiment of trading China Pharma Holdings stock suggests that some investors are interested at this time. China Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in China Pharma Holdings. The current market sentiment, together with China Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use China Pharma Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
China Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of China daily returns and investor perception about the current price of China Pharma Holdings as well as its diversification or hedging effects on your existing portfolios.
China |
Requested story not found. it has been either deleted or moved. View all stories for China Pharma Holdings.
China Pharma Latest Timeline
China Pharma is listed for 0.32. About 67.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.69. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Pharma Holdings recorded a loss per share of 0.91. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 6th of March 2024.Check out China Pharma Hype Analysis, China Pharma Correlation and China Pharma Performance. Note that the China Pharma Holdings information on this page should be used as a complementary analysis to other China Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is China Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Pharma. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 2.072 | Quarterly Revenue Growth (0.26) | Return On Assets (0.10) | Return On Equity (0.52) |
The market value of China Pharma Holdings is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Pharma's value that differs from its market value or its book value, called intrinsic value, which is China Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Pharma's market value can be influenced by many factors that don't directly affect China Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.